Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.

MLA

Ortiz, Michael V., et al. “Prohibitin Is a Prognostic Marker and Therapeutic Target to Block Chemotherapy Resistance in Wilms’ Tumor.” JCI Insight, vol. 4, no. 15, Aug. 2019. EBSCOhost, https://doi.org/10.1172/jci.insight.127098.

APA

Ortiz, M. V., Ahmed, S., Burns, M., Henssen, A. G., Hollmann, T. J., MacArthur, I., Gunasekera, S., Gaewsky, L., Bradwin, G., Ryan, J., Letai, A., He, Y., Naranjo, A., Chi, Y.-Y., LaQuaglia, M., Heaton, T., Cifani, P., Dome, J. S., Gadd, S., … Kentsis, A. (2019). Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor. JCI Insight, 4(15). https://doi.org/10.1172/jci.insight.127098

Chicago

Ortiz, Michael V, Saima Ahmed, Melissa Burns, Anton G Henssen, Travis J Hollmann, Ian MacArthur, Shehana Gunasekera, et al. 2019. “Prohibitin Is a Prognostic Marker and Therapeutic Target to Block Chemotherapy Resistance in Wilms’ Tumor.” JCI Insight 4 (15). doi:10.1172/jci.insight.127098.